Antibodies are vital tools in the ongoing effort to learn more about the human brain, both to understand the fundamental properties of neurons and neural circuits, and to identify the neurological diseases that affect it. It is therefore essential for those antibodies to be highly characterised and specific, so you can trust the data you obtain.
Atlas Antibodies' range of neuroscience antibodies are highly validated, showing high specificity and selectivity for their target proteins. The catalogue includes a wide range of primary monoclonal and polyclonal antibodies, specifically designed to recognise the diverse neurochemical cell types in rodent and human nervous systems, validated for use in immunohistochemistry (IHC), Western blot (WB) and immunocytochemistry/immunofluorescence (ICC-IF).
|
|
|
|
|
|
Why choose an Atlas antibody?
Validated by Enhanced Validation
Atlas Antibodies produce over 21,000 highly characterised primary antibodies, taking great care to validate for use in IHC, WB and ICC-IF. As an additional layer of security, they also perform enhanced validated on over 5,000 antibodies, using five methods of stringent validation.
Created by the Human Protein Atlas
The Triple A Polyclonal range is developed with the prestigious Human Protein Atlas project, with these antibodies validated in all major human tissues and organs, as well as 20 cancer tissues. In addition, each antibody in this range is supported with over 500 staining images.
Evidenced by science
Atlas Antibodies are used all over the world and referenced in thousands of scientific peer-reviewed papers.
